The "North America Intraocular Lens Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering.

The North America Intraocular Lens Market is expected to reach US$ 2.38 billion by 2033 from US$ 1.53 billion in 2024, with a CAGR of 5.00% from 2025 to 2033. An ageing population, a rise in cases of cataract, advanced surgery techniques, a growth in the prevalence of diabetes, and a demand for premium lenses are all propelling expansion in the North American intraocular lens market. Efforts by the government and NGOs towards enhancing access to eye care also drive market growth and adoption.

North America Intraocular Lens Industry Overview

When the normal lens of the eye is removed during cataract surgery, an artificial lens called an intraocular lens (IOL) is placed in its place. Made of silicone or acrylic, IOLs enable one to see clearly once more by properly focusing light into the retina. Numerous lens types, including monofocal, multifocal, toric, and extended depth of focus lenses, are used to enhance patients' quality of life after surgery by addressing a variety of visual issues like astigmatism, nearsightedness, and farsightedness.

Several significant factors are driving the strong growth of the intraocular lens (IOL) market in North America. Cataracts and other age-related vision problems are increasingly prevalent as the population ages. Advances in surgical techniques have improved accuracy and outcomes, which has promoted increased use of IOLs.

Another factor fueling demand is the increasing prevalence of diabetes, a recognized risk factor for cataracts. In addition, advances in high-end lenses such as extended depth-of-focus IOLs, multifocal lenses, and toric lenses are enhancing patient outcomes. Efforts by the government and non-governmental organizations to make cataract surgery available also contribute to the growth of the market in the region.

Growth Drivers for the North America Intraocular Lens Market

Rising ageing population

The intraocular lens (IOL) market in North America is greatly affected by the aging population. More than 10,000 Americans turn 65 each day, which contributes to the constant increase in age-related diseases such as cataracts. Age-related clouding of the eye's natural lens boosts the demand for intraocular lens implants and cataract surgery.

In addition, in the next decade, the population aged 80 and older will grow by nearly 50%, from 13.9 million to 20.8 million, far outpacing the 4.7% growth in the total U.S. population. As more older patients seek means to maintain their visual independence and quality of life, this demographic change is projected to have a significant effect on vision care needs. The growing population of elderly people is set to be a major driver of market growth as a result of increased utilization of premium IOLs and greater access to eye care services.

Increased Cataract Surgeries

The intraocular lens (IOL) market in North America is expanding substantially due to an upsurge in cataract surgeries. Growing prevalence of cataracts in the aging population is fueling demand for lens implants and cataract procedures. In November 2022, 1.8% of dementia in the United States was attributed to visual impairment, as per the NIH. As of 2050, the figure is projected to rise above 250,000 cases.

Demand for cataract surgeries is driven by the heightened vulnerability to vision impairment among elderly people, particularly those suffering from chronic illnesses such as dementia. Another ethnic group that suffers more from vision impairment is Hispanics (11%) compared to Blacks and non-Hispanic Whites (8.3%). Demand for intraocular lenses is increasing as ageing populations seek improved vision and an enhanced level of living. During the forecast period, the market will grow considerably as a result of the increasing demand for cataract surgery.

Technological Advancement

The North American intraocular lens (IOL) market is expanding largely because of technological advancements. Growing adoption stems from continued innovation in cataract surgical techniques and IOL design that enhance patient results. In April 2023, for instance, the FDA approved ZEISS Medical Technology's CT LUCIA 621P Monofocal IOL, an innovative aspheric, monofocal, single-piece C-loop IOL.

By improving optical function, this breakthrough technology provides patients with improved vision and enhanced visual comfort. Still fueling interest in premium IOLs are innovations such as femtosecond laser-assisted cataract surgery, which provides enhanced accuracy and faster recovery times. These technologies have enhanced patients' quality of life by providing them with access to a greater array of lens types, such as multifocal and toric lenses, which can be utilized to meet various visual needs.

Challenges in the North America Intraocular Lens Market

High Cost of Premium Lenses

In the North American market, the high price of high-end intraocular lenses (IOLs) is a major obstacle. Although they provide superior visual results, premium lenses like multifocal or toric IOLs are sometimes not covered by insurance. This restricts their adoption by rendering them unaffordable for certain patients. Patients may be deterred from selecting these cutting-edge solutions by the higher initial cost of these lenses and the additional costs associated with cataract surgery, which could hinder market expansion.

Regulatory Hurdles

In the North American intraocular lens (IOL) market, regulatory obstacles present a problem because the FDA clearance process for novel IOL technology can be costly and time-consuming. Innovative lenses take longer to become available because manufacturers must go through stringent clinical trials to guarantee safety and efficacy. Furthermore, additional regulatory review might be necessary for any modifications to IOL designs or materials. The quick release of novel, cutting-edge IOL solutions onto the market may be hampered by these drawn-out approval procedures and related expenses.

Key Players Analyzed: Company Overview, Key Persons, Recent Developments, Financial Insights

• Alcon Inc.
• Bausch Health Companies Inc.
• Hoya Corporation
• Johnson & Johnson
• STAAR Surgical Co
• Carl Zeiss Meditec AG
• Novartis AG
• USIOL Inc.

Key Attributes:

Key Topics Covered:

1. Introduction

2. Research & Methodology

2.1 Data Source

2.2 Research Approach

2.3 Forecast Projection Methodology

3. Executive Summary

4. Market Dynamics

4.1 Growth Drivers

4.2 Challenges

5. North America Intraocular Lens Market

5.1 Historical Market Trends

5.2 Market Forecast

6. North America Intraocular Lens Market Share Analysis

6.1 By Product

6.2 By Material

6.3 By End User

6.4 By Countries

7. Product

7.1 Monofocal IOL

7.2 Multifocal IOL

7.3 Toric IOL

7.4 Accommodative IOL

8. Material

8.1 Polymethyl meth Acrylate Material

8.2 Silicone Material

8.3 Hydrophobic and Hydrophylic Acrylic Material

8.4 Other Material

9. End Users

9.1 Hospitals

9.2 Ambulatory Surgery Centers

9.3 Ophthalmology Clinics

9.4 Eye Research Institutes

10. Countries

10.1 Canada

10.2 United States

10.3 Mexico

10.4 Rest of North America

11. Porter's Five Forces Analysis

11.1 Bargaining Power of Buyers

11.2 Bargaining Power of Suppliers

11.3 Degree of Rivalry

11.4 Threat of New Entrants

11.5 Threat of Substitutes

12. SWOT Analysis

12.1 Strength

12.2 Weakness

12.3 Opportunity

12.4 Threat

13. Key Players Analysis

For more information about this report visit https://www.researchandmarkets.com/r/dzqse5

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250912804294/en/